Close Menu

microarrays

AT A GLANCE PhD in Genetics from the University of California Davis. American Heart Association postdoctoral fellowship at Stanford University.

Affymetrix and DeCode Genetics have signed an agreement to use Affymetrix GeneChip technology to develop DNA-based tests for patient response to common disease treatments.

Seattle-area proteomics startup Prolinx plans to develop protein microarrays with a portion of $16.8 million it has just raised in a private financing round.

Nanogen and Motorola have settled their patent infringement dispute, with Nanogen agreeing to pay Motorola $5 million in cash and stock for a license to two claims of the patent at issue.

Genomic Solutions has signed an agreement with NuTec Sciences life sciences division to jointly develop an expanded microarray analysis platform for Genomic Solutions GeneTac microarray system.

The bead goes on at Lynx therapeutics, as the company continues to build up its roster of collaborators for its microbead-based Megaclone DNA detection technology and to increase its revenues from these collaborations.

Marrying microfluidics and microarray technology, Gene Logic s new spinoff Metrigenix is planning to market its Flow-thru Chip, a three-dimensional honeycomb of silicon microchannel probe surfaces that is designed to speed up hybridization times and increase probe sensitivity.

PATENT WATCH: Jul 20, 2001

Premium

Agilix Awarded Patent for Universal Microarray Texas A&M, Affymetrix scientists Awarded BioMarker Patents for Breast, Colon Cancer Boston Biomedica Receives Patent for Novel Hybridization Technology

Genetix of Hampshire, UK, has introduced Qselect, an automated robotic system for managing and developing genomic and cDNA libraries.

William Bennett, Ted Love.

Premium

Hyseq has appointed William Bennett as senior vice president of research.
Bennett previously worked with Hyseq CEO Ted Love at Genentech, where he served as team leader of the TNKase project and held numerous other R&D positions.

Pages

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.